Author/Authors :
Ghasemi, Mahmoud Department of Pediatrics - Health School - Isfahan University of Medical Sciences, Isfahan , Hashemipour, Mahin Department of Pediatric Endocrinology - Health School - Isfahan University of Medical Sciences, Isfahan , Hovsepian, Silva Health School - Isfahan University of Medical Sciences, Isfahan , Heiydari, Kamal Health School - Isfahan University of Medical Sciences, Isfahan , Sajadi, Ali Health School - Isfahan University of Medical Sciences, Isfahan , Hadian, Rezvaneh Health School - Isfahan University of Medical Sciences, Isfahan , Mansourian, Marjan Department of Biostatistics and Epidemiology - Health School - Isfahan University of Medical Sciences, Isfahan , Mirshahzadeh, Naghme Department of Pediatric Endocrinology - Health School - Isfahan University of Medical Sciences, Isfahan , Dalvi, Marzie Health School - Isfahan University of Medical Sciences, Isfahan
Abstract :
Background: Congenital hypothyroidism (CH) considered a common endocrine disorder in Iran. We report the epidemiologic
findings of CH screening program in Isfahan, seven years after its development, regarding the prevalence of transient CH (TCH) and
its screening properties comparing with permanent CH (PCH). Materials and Methods: In this cross-sectional study, children with
primary diagnosis of CH were studied. Considering screening and follow-up lab data and the decision of pediatric endocrinologists,
the final diagnosis of TCH was determined. Results: A total of 464,648 neonates were screened. The coverage percent of the CH
screening and recall rate was 98.9 and 2.1%, respectively. Out of which, 1,990 neonates were diagnosed with primary CH. TCH was
diagnosed in 1,580 neonates. The prevalence of TCH was 1 in 294 live births. 79.4% of patients with primary CH had TCH. Mean
of screening (54.7 ± 59.0 in PCH vs 21.8 ± 28.9 in TCH), recall (56.5 ± 58.8 in PCH vs 36.6 ± 45.0 in TCH), and thyroid stimulating
hormone (TSH) and mean of TSH before (2.0 ± 2.9 in PCH vs 1.6 ± 1.6 in TCH) and after (37.7 ± 29.5 in PCH vs 4.3 ± 1.9 in TCH)
discontinuing treatment at 3 years of age was significantly higher in PCH than TCH (P < 0.0000). Conclusion: The higher rate of
CH in Isfahan is mainly due to the transient form of the disease. Further studies for evaluating the role of other environmental,
autoimmune and/or genetic factors in the pathophysiology of the disease is warranted.